For decades, the story of dementia has been told through the lens of the wreckage it leaves behind, focusing on the sticky protein plaques that litter the brains of patients. But what if the true villain is not the aftermath of the battle, but the very first shot fired—a preemptive act of cellular
Picture a high-stakes medical decision resting on the shoulders of a systematic review, the gold standard of evidence-based research, where every detail could impact patient lives. In this critical arena, artificial intelligence (AI), particularly large language models (LLMs), has emerged as a
Picture a hospital radiology department swamped with thousands of MRI scans, each holding the key to a patient’s life-changing diagnosis, yet delays stretch on for weeks due to a shortage of experts. What if a machine could step in, instantly flagging critical brain abnormalities like strokes or
As I sit down with Ivan Kairatov, a renowned biopharma expert with a passion for cutting-edge technology and innovation, I’m eager to dive into the transformative potential of sweat as a diagnostic biofluid. With years of experience in research and development, Ivan has been at the forefront of
Imagine a world where the intricate dance of proteins and lipids within cells can be mapped and understood by any scientist, regardless of their technical background. Spatial omics, a field dedicated to pinpointing the locations of these critical molecules in tissues, holds the key to unraveling
Imagine a future where a child’s medical treatment is as unique as their fingerprint, crafted precisely to match their genetic makeup, lifestyle, and environment, ensuring the best possible outcome with minimal side effects. This vision is no longer a distant dream but a tangible reality unfolding
